Researcheri3S - Instituto de Investigação e Inovação em Saúde, Universidade do PortoActive in the last 2 years

Fátima Martel

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0002-0525-3416; OpenAlex author ID A5049849503.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 2 (first author 0, last author 1)
Pancreatic cancer trials: 0
Pancreatic cancer grants: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Cláudia Silva · 2 shared papers, 2023–2024
- Paper Effect of Sodium-Glucose Co-Transporter 2 Inhibitors Combined with Metformin on Pancreatic Cancer Cell Lines. DOI 10.3390/ijms25189932 ↗
- Paper Gallic acid markedly stimulates GLUT1-mediated glucose uptake by the AsPC-1 pancreatic cancer cell line. DOI 10.1139/cjpp-2022-0260 ↗
André Cristovão · 1 shared paper, 2024
- Paper Effect of Sodium-Glucose Co-Transporter 2 Inhibitors Combined with Metformin on Pancreatic Cancer Cell Lines. DOI 10.3390/ijms25189932 ↗
Sílvia M. Torres · 1 shared paper, 2023
- Paper Gallic acid markedly stimulates GLUT1-mediated glucose uptake by the AsPC-1 pancreatic cancer cell line. DOI 10.1139/cjpp-2022-0260 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.